Kartalax
Kartalax has been studied in 1 paper since 2023: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jan 1, 2023: “Chondrocytes secretory phenotype associated with aging: role in the pathogenesis of osteoarthritis and prospects for peptide bioregulation”.
1 paper studies it1 findingUpdated
What did studies of Kartalax find?
1Studies of Kartalax measured 1 outcome; the most studied are osteoarthritis (1 study).
Osteoarthritis
downin humans1
1 study
Osteoarthritis
downin humans1
Kartalax decreases osteoarthritis in humans.
“AED tripeptide (Kartalax) have shown high efficacy in animal models of OA and oral administration in patients with OA of older age groups.”
Reviewosteoarthritisoral
Advances in gerontology = Uspekhi gerontologii